Patterns of chromosomal imbalances in invasive breast cancer

International Journal of Cancer

Volumn 89, Issue 3, 2000, Pages 305-310

  Richard, Frank ^a   Pacyna Gengelbach, Manuela ^a   Schlüns, Karsten ^a   Fleige, Barbara ^a   Winzer, Klaus J ^a   Szymas, Janusz ^b   Dietel, Manfred ^a   Petersen, Iver ^a   Schwendel, Anke ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Dept of Chemistry and Biochemistry ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CLASSIFICATION; CHROMOSOME 11Q; CHROMOSOME 12P; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 19; CHROMOSOME 22Q; CHROMOSOME 4; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME ABERRATION; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; NEOPLASM INVASIVENESS; NUCLEIC ACID HYBRIDIZATION; PHENOTYPE; RECEPTORS, ESTROGEN;

EID: 0033918825     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000520)89:3<305::AID-IJC15>3.0.CO;2-8     Document Type: Article

References (33)

1. ANZICK, S.L., KONONEN, J., WALKER, R.L., AZORSA, D.O., TANNER, M.M., GUAN, X.Y., SAUTER, G., KALLIONIEMI, O.P., TRENT, J.M. and MELTZER, P.S., AIBI, a steroid receptor coactivator amplified in breast and ovarian cancer. Science, 277, 965-968 (1997).
2. BERX, G., CLETON-JANSEN, A.M., STRUMANE, K., DE LEEUW, W.J., NOLLET, F., VAN ROY, F. and CORNELISSE, C., E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene, 13, 1919-1925 (1996).
3. COURJAL, F. and THEILLET, C., Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res., 57, 4368-4377 (1997).
4. EIRIKSDOTTIR, G., JOHANNESDOTTIR, G., INGVARSSON, S., BJORNSDOTTIR, I.B., JONASSON, J.G., AGNARSSON, B.A., HALLGRIMSSON, J., GUDMUNDSSON, J., EGILSSON, V., SIGURDSSON, H. and BARKARDOTTIR, R.B., Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Europ. J. Cancer, 34, 2076-2081 (1998).
5. ISOLA, J., VISAKORPI, T., HOLLI, K. and KALLIONIEMI, O.P., Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J. nat. Cancer Inst., 84, 1109-1114 (1992).
6. ISOLA, J.J., KALLIONIEMI, O.P., CHU, L.W., FUQUA, S.A., HILSENBECK, S.G., OSBORNE, C.K. and WALDMAN, F.M., Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Amer. J. Pathol., 147, 905-911 (1995).
7. JAMES, L.A., MITCHELL, E.L., MENASCE, L. and VARLEY, J.M., Comparative genomic hybridization of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma. Oncogene, 14, 1059-1065 (1997).
8. JENG, M.H., SHUPNIK, M.A., BENDER, T.P., WESTIN, E.H., BANDYOPADHYAY, D., KUMAR, R., MASAMURA, S. and SANTEN, R.J., Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Endocrinology, 139, 4164-4174 (1998).
9. KALLIONIEMI, A., KALLIONIEMI, O.P., SUDAR, D., RUTOVITZ, D., GRAY, J.W., WALDMAN, F. and PINKEL, D., Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science, 258, 818-821 (1992).
10. KALLIONIEMI, A., KALLIONIEMI, O.P., PIPER, J., TANNER, M., STOKKE, T., CHEN, L., SMITH, H.S., PINKEL, D., GRAY, J.W. and WALDMAN, F.M., Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. nat. Acad. Sci. (Wash.), 91, 2156-2160 (1994).
11. KREIPE, H., FEIST, H., FISCHER, L., FELGNER, J., HEIDORN, K., METTLER, L. and PARWARESCH, R., Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer. Cancer Res., 53, 1956-1961 (1993).
12. MARCHETTI, A., BUTTITA, F., PELLEGRINI, S., CAMPANI, D., DIELLA, F., CECCHETTI, D., CALLAHAN, R. and BISTOCCHI, M., p53 mutations and histological type of invasive breast carcinoma. Cancer Res., 53, 4665-4669 (1993).
13. MARTINAZZI, M., CRIVELLI, F., ZAMPATTI, C. and MARTINAZZI, S., Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma. J. clin. Pathol., 46, 009-1010 (1993).
14. NISHIZAKI, T., CHEW, K., CHU, L., ISOLA, J., KALLIONIEMI, A., WEIDNER, N. and WALDMAN, F.M., Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int. J. Cancer, 74, 513-517 (1997a).
15. NISHIZAKI, T., DE VRIES, S., CHEW, K., GOODSON III, W.H., LJUNG, B.M., THOR, A. and WALDMAN, F.M., Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridization. Genes Chromosom. Cancer, 19, 267-272 (1997b).
16. PAIK, S., BRYANT, J., PARK, C., FISHER, B., TAN-CHIU, E., HYAMS, D., FISHER, E.R., LIPPMANN, M.E., WICKERHAM, D.L. and WOLMARK, N., erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer. J. nat. Cancer Inst., 90, 1361-1370 (1998).
17. PANDIS, N., BARDI, G., MITELMAN, F. and HEIM, S., Deletion of the short arm of chromosome 3 in breast carcinomas. Genes Chromosom. Cancer, 18, 241-245 (1997).
18. PETERSEN, I., and 13 OTHERS, Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res., 57, 2331-2335 (1997).
19. PETERSEN, S., ANINAT-MEYER, M., SCHLÜNS, K., GELLERT, K., DIETEL, M. and PETERSEN, I., Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Brit. J. Cancer, 82, 65-73 (2000)
20. 1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J. biol. Chem., 272, 10882-10894 (1997).
21. RIED, T., JUST, K.E., HOLTGREVE-GREZ, H., DU MANOIR, S., SPEICHER, M.R., SCHRÖCK, E., LATHAM, C., BLEGEN, H., ZETTERBERG, A., CREMER, T. and AUER, G., Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res., 55, 5415-5423 (1995).
22. ROTH, K., WOLF, G., DIETEL, M. and PETERSEN, I., Image analysis for comparative genomic hybridization based on a karyotyping program for Windows. Anal. quant. Cytol. Histol., 19, 461-474 (1997).
23. ROYLANCE, R., GORMAN, P., HARRIS, W., LIEBMANN, R., BARNES, D., HANBY A. and SHEER, D., Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res., 59, 1433-1436 (1999).
24. SCHWENDEL, A., RICHARD, F., LANGRECK, H., KAUFMANN, O., LAGE, H., WINZER, K.J., PETERSEN, I. and DIETEL, M., Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q. Brit. J. Cancer, 78, 806-811 (1998a).
25. SCHWENDEL, A., RICHARD, F., PACYNA-GENGELBACH, M., PETERSEN, I., WINZER, K.J. and DIETEL, M., DNA copy number changes in lobular breast carcinomas. 17th International Cancer Congress, pp.753-757. Rio de Janeiro, Brazil (1998b).
26. SILVERSTEIN, M.J., LEWINSKY, B.S., WAISMAN, J.R., GIERSON, E.D., COLBURN, W.J., SENOFSKY, G.M. and GAMAGAMI, P., Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer, 73, 1673-1677 (1994).
27. SLAMON, D.J., CLARK, G.M., WONG, S.G., LEVIN, W.J., ULLRICH, A. and MCGUIRE, W.L., Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogene. Science, 235, 177-181 (1987).
28. TAVASSOLI, F.A. (ED.), Pathology of the breast, Appleton & Lange, Norwalk, Ct (1992).
29. TIRKKONEN, M., TANNER, M., KARHU, R., KALLIONIEMI, A., ISOLA, J. and KALLIONIEMI, O.P., Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosom. Cancer, 21, 177-184 (1998).
30. VOS, C.B.J., CLETON-JANSEN, A.M., BERX, G., DE LEEUW, W.J.F., TER HAAR, N.T., VAN ROY, F., CORNELISSE, C.J., PETERSE, J.L. and VAN DE VIJVER, M.J., E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Brit. J. Cancer, 76, 1131-1133 (1997).
31. WICK, W., PETERSEN, I., SCHMUTZLER, R.K., WOLFARTH, B., LENARTZ, D., BIERHOFF, E., HUMMERICH, J., MULLER, D.J., STANGL, A.P., SCHRAMM, J., WIESTLER, O.D. and VON DEIMLING, A., Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene, 12, 973-980 (1996).
32. WINQVIST, R., HAMPTON, G.M., MANNERMAA, A., BLANCO, G., ALAVAIKKO, M., KIRINIEMI, H., TASKINEN, P.J., EVANS, G.A., WRIGHT, F.A., NEWSHAM, I. and CAVENEE, W.K., Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res., 55, 2660-2664 (1995).
33. YEATMAN, T.J., CANTOR, A.B., SMITH, T.J., SMITH, S.K., REITGEN, D.S., MILLER, M.S., KU, N.N., BAEKEY, P.A. and COX, C.E., Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann. Surg., 222, 549-559 (1995).